Prognosis and Management of Stage 1 Grade 1 Clear Cell Renal Cell Carcinoma

Introduction to Prognosis

The prognosis for stage 1 grade 1 clear cell renal cell carcinoma after partial nephrectomy is excellent, with a 5-year survival rate of 91-96% and a 5-year metastasis-free survival of approximately 97%, according to the Annals of Oncology 1

A patient with a pT1a tumor, grade 1 nuclear grade, tumor size <10 cm, no lymph node involvement, and no tumor necrosis is classified as low-risk with a total SSIGN score of 0-2 points, corresponding to a 97.1% 5-year metastasis-free survival, as per the Annals of Oncology 1, 2, 3
The SSIGN scoring system assigns 0 points for a pT1a tumor 1, 0 points for grade 1 nuclear grade 4, 0 points for tumor size <10 cm 4, 0 points for no lymph node involvement (pNx or pN0) 3, and 0 points for no tumor necrosis 1

The European Society for Medical Oncology recommends no adjuvant treatment for patients with localized disease after complete surgical resection, with active surveillance with imaging remaining the standard of care 1, 2, 4
Partial nephrectomy is the appropriate surgical choice, offering lower renal function impairment and equivalent oncological survival outcomes compared to radical nephrectomy for T1 tumors, preserving long-term renal function and quality of life, according to the European Association of Urology [5] [5]

The American Urological Association reports cancer-specific survival rates of 80-90% at 5 years for clinically localized disease (Stage I-II), with Stage I representing the most favorable end of this spectrum 6, 7
Stage I renal cell carcinoma has a 5-year survival rate of 91-96% 8, 9, 10
Stage II renal cell carcinoma has a 5-year survival rate of 72.8-88% 8, 9, 10
Stage III renal cell carcinoma has a 5-year survival rate of 55-67% 8, 9
Stage IV renal cell carcinoma has a 5-year survival rate of 16.9-23% 8, 9

Tumor size is a prognostic factor, with smaller tumors having better outcomes, and tumors up to 7 cm having slightly worse prognosis 8
Surgical intervention, such as partial or radical nephrectomy, achieves excellent survival rates for Stage I RCC, with partial nephrectomy being the preferred option for tumors <7 cm 8, 11, 10

Approximately 30% of recurrences occur after 5 years of treatment, necessitating long-term surveillance beyond the typical 5-year benchmark 6, 7